Protocols in Revision

Hodgkin Lymphoma

• Doxorubicin 25 / Vinblastine 6 / Dacarbazine 375 / Brentuximab Vedotin 1,2, Hodgkin Lymphoma PID 587 V1.1
• Doxorubicin 25 / Vinblastine 6 / Dacarbazine 375 / Nivolumab 240, Hodgkin Lymphoma PID 2777 V2.0
• Doxorubicin 25 / Vinblastine 6 / Dacarbazine 375 / Nivolumab 240, Hodgkin Lymphoma, part B PID 1375 V2.0
• Doxorubicin 25 / Vinblastine 6 / Dacarbazine 375 / Nivolumab 240, Hodgkin Lymphoma, Part B, Variant 1 PID 1970 V2.0
• TEAM - Thiotepa 5 / Etoposide 100 / Cytarabine 200 / Melphalan 140, Autologous Stem Cell Transplantation PID 406 V2.1

Breast Cancer

• Tucatinib 300 / Capecitabine 1000 / Trastuzumab 600, Breast Cancer PID 1763 V1.2

Mantle Cell Lymphoma

• TEAM - Thiotepa 5 / Etoposide 100 / Cytarabine 200 / Melphalan 140, Autologous Stem Cell Transplantation PID 406 V2.1

Multiple Myeloma

• HD 7 - Bortezomib 1.3 / Lenalidomide 25 / Dexamethasone 20, Multiple Myeloma, Induction, Cycle 1-3 PID 40 V1.1
• HD 7 - Lenalidomide 10 / Dexamethasone 20, Multiple Myeloma, maintenance, cycle 1 PID 43 V1.1
• HD 7 - Lenalidomide 10, multiple myeloma, maintenance, cycle 2-3 PID 44 V1.1
• HD 7 - Lenalidomide 15, multiple myeloma, maintenance, cycle 4+ PID 37 V1.1

NHL, B-Cell Type, Diffuse Large Cell

• TEAM - Thiotepa 5 / Etoposide 100 / Cytarabine 200 / Melphalan 140, Autologous Stem Cell Transplantation PID 406 V2.1

NHL, B-Cell Type, Follicular Grade I-IIIa

• TEAM - Thiotepa 5 / Etoposide 100 / Cytarabine 200 / Melphalan 140, Autologous Stem Cell Transplantation PID 406 V2.1

NHL, B-Cell Type, Follicular grade IIIb

• TEAM - Thiotepa 5 / Etoposide 100 / Cytarabine 200 / Melphalan 140, Autologous Stem Cell Transplantation PID 406 V2.1

Stem Cell Transplantation, Allogeneic

• Busulfan 3.2 / Cyclophosphamide 60, Allogeneic Stem Cell Transplantation, MAC PID 882 V1.1

Stem Cell Transplantation, Autologous

• TEAM - Thiotepa 5 / Etoposide 100 / Cytarabine 200 / Melphalan 140, Autologous Stem Cell Transplantation PID 406 V2.1